Propanc Biopharma, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Mar 2026Filed 17/07/2026 | Dec 2025Filed 17/07/2026 | Sep 2025Filed 17/07/2026 | Mar 2025Filed 17/07/2026 | Dec 2024Filed 17/07/2026 | Sep 2024Filed 17/07/2026 | Mar 2024Filed 15/05/2025 | Dec 2023Filed 15/05/2025 |
|---|---|---|---|---|---|---|---|---|
| −$6.4 | −$3.1 | −$4.8 | −$54 | −$0.4 | −$0.4 | −$0.5 | −$0.6 | |
| −$7.09 | −$0.30 | −$0.39 | −$312.46 | −$32.23 | −$35.97 | −$545.79 | −$1559.55 | |
| — | 13 | 12 | — | 0 | — | — | — |
Trend